- Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study2008 | First Faculty of Medicine
- Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study +12008 | Faculty of Medicine in Hradec Králové
- Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study2008 | Second Faculty of Medicine
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome2011 | Publication without faculty affiliation
- Apixaban versus Warfarin in Patients with Atrial Fibrillation2011 | Publication without faculty affiliation